Investigation in a background level exposure setting in Sweden.
Eight PFASs analyzed in biobank samples from disease-free baseline.
Coronary heart disease was based on clinical diagnoses in national registers.
No consistent evidence of an association between PFAS levels and coronary heart disease.
Association with PFHpA found in this study could be a chance finding.